Advertisement
Illumina, Inc.

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

ILMNโ—NASDAQ
HealthcareMedical - Diagnostics & Research
$177.74
$2.65(1.52%)
U.S. Market is Open ยท 11:08
Advertisement

Illumina, Inc. (ILMN)

Meyka AI Score

Z

Key Financials

Market Cap26.9B
P/E Ratio32.04
EPS (TTM)$5.03
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$171.03
3 Months$202.26
1 Year Target$119.41

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $119.41.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.04 and a market capitalization of 26.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.46%
5-Day Change
9.78%
1-Month Change
22.32%
3-Month Change
40.77%
6-Month Change
31.64%
Year-to-Date (YTD) Change
35.45%
1-Year Change
90.55%
3-Year Change
-4.74%
5-Year Change
-61.49%
All-Time (Max) Change
833.53%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

89,700 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions